Related Experiment Videos
An aggrecan-degrading activity associated with chondrocyte membranes
C J Billington1, I M Clark, T E Cawston
1Department of Rheumatology, School of Clinical and Medical Sciences, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK.
The Biochemical Journal
|November 10, 1998
Summary
Cartilage aggrecan breakdown involves aggrecanase, an enzyme whose identity is unclear. Researchers found this metalloproteinase activity on chondrocyte membranes, distinct from matrix metalloproteinase (MMP) inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Rheumatology
Background:
- Aggrecan is a key cartilage component degraded during joint diseases.
- Aggrecanase mediates aggrecan cleavage at a specific site, but its identity remains unknown.
- Understanding aggrecanase is crucial for developing treatments for cartilage degradation.
Purpose of the Study:
- To identify and characterize the aggrecanase enzyme responsible for cartilage aggrecan breakdown.
- To determine the cellular localization and enzymatic properties of aggrecanase.
Main Methods:
- Utilized membranes from stimulated chondrocytes to assay aggrecanase activity.
- Employed antibodies recognizing aggrecanase-generated N-termini to detect cleavage.
- Tested inhibition by tissue inhibitors of metalloproteinases (TIMPs) 1 and 2.
Main Results:
- Chondrocyte membranes exhibited aggrecanase activity, generating specific aggrecan fragments.
- The enzyme activity was confirmed as a metalloproteinase.
- Aggrecanase activity was not inhibited by TIMP 1 or TIMP 2, suggesting it may not be a matrix metalloproteinase (MMP).
Conclusions:
- Aggrecanase activity is associated with chondrocyte membranes.
- The enzyme is a metalloproteinase but distinct from known MMPs inhibited by TIMPs.
- Further research is needed to elucidate the precise identity and function of this aggrecanase.